Cancer under pressure: which signals are activated?

30 Jun 2023 | Discover home page, Discover SigDyn

Cancer under pressure: which signals are activated? mechanical forces, cancer, mechanosensing,  compression, confinement,  targeted therapies,  cell signaling. Julie Guillermet-Guibert Team SigDyn Integrated cellular signalling and PI3K isoforms In living organisms,...

Cancer: a key mechanism for improving immunotherapies identified by a Toulouse team

30 Jun 2023 | Discover GENIM, Discover home page

Cancer: a key mechanism for improving immunotherapies identified by a Toulouse team Cancer, Immunology, Immunotherapy, Lymphocytes, Depletion. Ludovic Martinet Team GENIM Genomic and immunology of myeloma A team from the Centre de Recherches en Cancérologie de...

The power of the intestine against metastases

12 Jun 2023 | Discover home page, Discover T2i

The power of the intestine against metastases CD8-Positive T-Lymphocytes Neoplasms of the Colon Humans Intégrins Prognosis Virginie Feliu and Dr Christel Devaud Team’s T2i Intestinal α4b7 CD8 T lymphocytes, activated locally in colon tumours, are key effectors...

The level of von Willebrand factor is a pronostic marker in patients with metastatic melanoma treated by immune checkpoint inhibitors

5 Jun 2023 | Discover home page, Discover Signather

The level of von Willebrand factor is a pronostic marker in patients with metastatic melanoma treated by immune checkpoint inhibitors Immunotherapy; Melanoma; Translational Medical Research; Tumor Microenvironment. Laura Keller- Team SIGNATHER : Cell Signalling,...

Encouraging phase 1 results of hypofractionated stereotactic re-irradiation in combination with Durvalumab in recurrent Glioblastoma.

25 May 2023 | Discover home page, Discover RADOPT

Encouraging phase 1 results of hypofractionated stereotactic re-irradiation in combination with Durvalumab in recurrent Glioblastoma. Durvalumab; deep learning; hypofractionated stereotactic re-irradiation; phase I clinical trial; recurrent glioblastoma; predictive...

Dr Marc Poirot is laureate of the Schroepfer Prize 2023

27 Apr 2023 | Discover home page, Discover INOV, Talents et prix en

Talents& awards AWARD Dr Marc Poirot is the winner of the prestigious Schroepfer Prize awarded by the American Oil Chemists’ Society (AOCS), which will be presented to him on 2 May 2023 at the Denver-USA congress. The AOCS is an American learned society...